Actionable news
All posts from Actionable news
Actionable news in CARA: CARA THERAPEUTICS Inc,

Cara Therapeutics's VP-Research & Development just disposed of 6,000 shares

Frederique Ph.D. Menzaghi, Cara Therapeutics's VP-Research & Development, recently disposed of 6,000 shares of the company. The disposals took place at $9.00 per share, on April 20, 2016. Menzaghi still owns 123,000 shares of the company. Menzaghi operates out of Shelton, CT. Some additional info was provided as follows:

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2015.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Cara Therapeutics makes a similar move, sign up!

Other recent filings from the company include the following:

Cara Therapeutics's President & CEO was just granted 194,000 options - April 1, 2016
Cara Therapeutics's Chief Medical Officer was just granted 66,000 options - April 1, 2016
Cara Therapeutics's Chief Financial Officer was just granted 48,000 options - April 1, 2016